X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global Waldenstrom's Macroglobulinemia (WM) Treatment Companies

This report lists the top Global Waldenstrom's Macroglobulinemia (WM) Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Waldenstrom's Macroglobulinemia (WM) Treatment industry.

Global Waldenstrom's Macroglobulinemia (WM) Treatment Top Companies

  1. BeiGene

  2. TG Therapeutics, Inc.

  3. Curis, Inc.

  4. X4 Pharmaceuticals, Inc.

  5. Pharmacyclics LLC

*Disclaimer: Top companies sorted in no particular order

 Global Waldenstrom's Macroglobulinemia (WM) Treatment Market Major Players

Global Waldenstrom's Macroglobulinemia (WM) Treatment Market Concentration

Global Waldenstrom's Macroglobulinemia (WM) Treatment Market Concentration

Global Waldenstrom's Macroglobulinemia (WM) Treatment Company List

                  • Johnson & Johnson Services, Inc.

                  • AbbVie Inc.

                  • Takeda Pharmaceutical Company Limited

                  • BeiGene

                  • AstraZeneca

                  • Cellectar Biosciences, Inc

                  • TG Therapeutics

                  • Curis, Inc.

                  • X4 Pharmaceuticals

                  • InnoCare

                  • Ascentage Pharma

                  • Pharmacyclics LLC


              Specific to Global Waldenstrom's Macroglobulinemia (WM) Treatment Market
              Need More Details On Market Players And Competitors?
              Download Sample

              Waldenstrom's Macroglobulinemia (WM) Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)